PRESS RELEASE published on 09/02/2025 at 13:00, 6 months 18 days ago Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism Moderna, Inc. to present abstracts on mRNA therapeutics at the 2025 ICIEM including PA, MMA, and GSD1a programs in Kyoto, Japan. Company's first time presenting data for MMA and GSD1a Moderna Inc. MRNA Therapeutics ICIEM Abstracts Kyoto Japan
BRIEF published on 08/27/2025 at 19:29, 6 months 24 days ago Les vaccins Moderna contre la COVID-19 mis à jour approuvés par la FDA américaine Approbation De La FDA Moderne Vaccin Contre Le Covid-19 Variante Du SRAS-CoV-2 Spikevax Et MNEXSPIKE
BRIEF published on 08/27/2025 at 19:29, 6 months 24 days ago Moderna's Updated COVID-19 Vaccines Approved by U.S. FDA FDA Approval COVID-19 Vaccine Moderna SARS-CoV-2 Variant Spikevax And MNEXSPIKE
PRESS RELEASE published on 08/27/2025 at 19:24, 6 months 24 days ago Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 Moderna announces FDA approval for updated Spikevax® and mNEXSPIKE® COVID-19 vaccines targeting LP.8.1 variant to prevent severe outcomes. Vaccines available soon FDA Approval Moderna COVID-19 Vaccines Spikevax MNEXSPIKE
BRIEF published on 08/22/2025 at 15:30, 6 months 29 days ago Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine COVID-19 Vaccine Moderna Health Canada Approval Canadian Manufacturing Biomanufacturing Leadership
BRIEF published on 08/22/2025 at 15:30, 6 months 29 days ago Moderna reçoit l'approbation de Santé Canada pour son vaccin contre la COVID-19 mis à jour Moderne Vaccin Contre Le Covid-19 Fabrication Canadienne Approbation De Santé Canada Leadership En Bioproduction
PRESS RELEASE published on 08/22/2025 at 15:25, 6 months 29 days ago Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 Moderna's Spikevax COVID-19 vaccine for SARS-CoV-2 LP.8.1 variant authorized in Canada, with all 2025 doses produced domestically. Leadership in biomanufacturing highlighted COVID-19 Vaccine Canada Moderna Spikevax Biomanufacturing
BRIEF published on 08/21/2025 at 13:05, 6 months 30 days ago Moderna participera aux principales conférences de septembre 2025 Conférences D'investisseurs Moderne Webcast En Direct Médecine À Base D'ARNm Présentation Des Soins De Santé
BRIEF published on 08/21/2025 at 13:05, 6 months 30 days ago Moderna to Participate in Major September 2025 Conferences Investor Conferences MRNA Medicine Moderna Live Webcast Healthcare Presentation
PRESS RELEASE published on 08/21/2025 at 13:00, 6 months 30 days ago Moderna to Present at Upcoming Conferences in September 2025 Moderna, Inc. to participate in upcoming investor conferences. The company's innovative mRNA technology redefines medicine creation, focusing on infectious diseases, oncology, and more Investor Conferences Healthcare COVID-19 Vaccine MRNA Technology Moderna
Published on 03/20/2026 at 21:15, 4 hours 35 minutes ago Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 12 hours 20 minutes ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 13 hours 20 minutes ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/20/2026 at 22:45, 3 hours 5 minutes ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 4 hours 45 minutes ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 4 hours 45 minutes ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 4 hours 50 minutes ago BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 5 hours 45 minutes ago INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action
Published on 03/20/2026 at 19:00, 6 hours 50 minutes ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 6 hours 50 minutes ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 7 hours 35 minutes ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 7 hours 35 minutes ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
